Who Paid My Doc
InPen
Device Continuous Glucose Monitoring
PDI 10862088000344
General payments
$2,042,251
Research payments
$9,648
Through program year 2021, $2,042,251 in general payments and $9,648 in research payments were reported against InPen (Continuous Glucose Monitoring).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | General | $2,042,251 | 5,923 |
| 2021 | Research | $9,648 | 3 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.
The top 5 of 77 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.
The top 5 of 49 states; each share is of general payments naming this product in 2021 where a state was reported.
Records
5,923 general · 3 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.